midodrine has been researched along with Autoimmune Disease in 3 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olivera-Martinez, M | 1 |
| Martinez, MO | 1 |
| Sayles, H | 1 |
| Vivekanandan, R | 1 |
| D' Souza, S | 1 |
| Florescu, MC | 1 |
| Goldstein, DS | 1 |
| Holmes, C | 1 |
| Dendi, R | 1 |
| Li, ST | 1 |
| Brentzel, S | 1 |
| Vernino, S | 1 |
| Rovit, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Plasma Exchange for Autoimmune Autonomic Failure[NCT00359346] | 3 participants | Observational | 2006-07-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for midodrine and Autoimmune Disease
| Article | Year |
|---|---|
Hepatorenal syndrome: are we missing some prognostic factors?
Topics: Albumins; Alcoholism; Autoimmune Diseases; Creatinine; End Stage Liver Disease; Female; Hepatitis C; | 2012 |
Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor.
Topics: Adrenergic alpha-Agonists; Aged; Autoantibodies; Autoimmune Diseases; Autonomic Nervous System; Auto | 2002 |
Autonomic failure: observations of a physician-patient.
Topics: Aged, 80 and over; Antibodies; Autoimmune Diseases; Autonomic Nervous System Diseases; Drug Therapy, | 2007 |